Search Results - "Jesús Vivancos, Maria"
-
1
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study
Published in Nature communications (18-02-2021)“…Changes in the microbiota have been linked to persistent inflammation during treated HIV infection. In this pilot double-blind study, we study 30 HIV-infected…”
Get full text
Journal Article -
2
Case report: From monkeypox pharyngitis to myopericarditis and atypical skin lesions
Published in Frontiers in cardiovascular medicine (05-01-2023)“…A global outbreak of the human monkeypox virus (HMPXV), first identified in May 2022, was declared a health emergency of international concern on 23 July 2022…”
Get full text
Journal Article -
3
Global DNA methylation and telomere length as markers of accelerated aging in people living with HIV and non-alcoholic fatty liver disease
Published in BMC genomics (23-09-2023)“…Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a comorbidity that generally increases in people living with HIV (PLWH). This condition is…”
Get full text
Journal Article -
4
Impact of a structured HIV testing program in a hospital emergency department and a primary care center
Published in PloS one (01-08-2019)“…HIV testing guidelines are poorly implemented in most clinical settings. The best screening strategy and healthcare scenario are still unknown. The aim of our…”
Get full text
Journal Article -
5
Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers
Published in Microbiome (22-10-2024)“…Despite effective antiretroviral therapy, people with HIV (PWH) experience persistent systemic inflammation and increased morbidity and mortality. Modulating…”
Get full text
Journal Article -
6
Hepatitis C and HIV combined screening in primary care: A cluster randomized trial
Published in Journal of viral hepatitis (01-02-2021)“…Hepatitis C virus (HCV) and HIV are major causes of worldwide disease. We aimed to evaluate the effect of a combined screening programme, which included a…”
Get full text
Journal Article -
7
Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis
Published in PloS one (25-07-2018)“…Despite high response rates associated to hepatitis C virus (HCV) treatment, no protective immunity is acquired, allowing for reinfection and continued…”
Get full text
Journal Article -
8
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
Published in Frontiers in cellular and infection microbiology (26-06-2023)“…Second-generation integrase strand transfer inhibitors (INSTIs) are preferred treatment options worldwide, and dolutegravir (DTG) is the treatment of choice in…”
Get full text
Journal Article -
9
Design and Proof of Concept of a Web-Based Questionnaire to Identify Patients at Risk for HIV and HCV Infection
Published in Biomedicines (01-08-2024)“…Despite remarkable improvement in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) care continuum, the rate of late diagnosis of HIV and HCV…”
Get full text
Journal Article -
10
Impact of COVID-19 on the Care of Patients with HIV Infection
Published in Journal of clinical medicine (07-06-2023)“…The COVID-19 pandemic and associated lockdown measures have been associated with substantial disruptions to health care services, including screening for human…”
Get full text
Journal Article -
11
An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population
Published in Microbiology spectrum (27-04-2022)“…Despite the effectiveness of available treatments, hepatitis C virus (HCV) remains a major public health problem, mainly due to the high percentage of…”
Get full text
Journal Article -
12
Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties
Published in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (01-09-2017)“…Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with…”
Get more information
Journal Article -
13
Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates
Published in PloS one (02-07-2019)“…Late HIV diagnosis remains one of the challenges in combating the epidemic. Primary care providers play an important role in screening for HIV infection. Our…”
Get full text
Journal Article -
14
Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting
Published in HIV research & clinical practice (26-04-2019)“…There are scarce data on the combination of dolutegravir (DTG) plus rilpivirine (RPV) in the real world, including patients with hepatitis C virus (HCV)…”
Get full text
Journal Article -
15
Management of Comorbidities in Treated HIV Infection: A Long Way to Go: HIV, comorbidities and aging
Published in International journal of antimicrobial agents (01-01-2022)“…Modern ART has now achieved the goal of maintaining HIV RNA suppression with minimum drug-related toxicities. Indeed, in high-income settings, the main health…”
Get full text
Journal Article -
16
Human Monkeypox in People With HIV: Transmission, Clinical Features, and Outcome
Published in Open forum infectious diseases (01-11-2022)“…We describe the first 25 persons with HIV diagnosed with human monkeypox virus (MPXV) in our hospital in an ongoing outbreak in Spain. Proctitis was the…”
Get full text
Journal Article -
17
Maraviroc reactivates HIV with potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells
Published in Biochemical pharmacology (01-12-2020)“…[Display omitted] Human immunodeficiency virus (HIV) remains incurable due to latent reservoirs established in non-activated CD4 T cells. Current efforts to…”
Get full text
Journal Article -
18
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
Published in Journal of antimicrobial chemotherapy (06-11-2023)“…Abstract Objectives To evaluate the efficacy and safety of the two-pill regimen bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus…”
Get full text
Journal Article -
19
-
20
Recently acquired hepatitis C: Epidemiological characteristics and treatment response in a large cohort of MSM living with HIV in Madrid
Published in Enfermedades infecciosas y microbiología clínica (01-10-2024)“…We analyzed epidemiological, clinical characteristics, and the response to treatment in people living with HIV (PLHIV) who recently acquired hepatitis C (RAHC)…”
Get full text
Journal Article